No, do not use rectal suppositories in patients with a colostomy
Rectal bisacodyl suppositories should not be used in patients with a colostomy because the rectum is bypassed by the surgical diversion, making rectal administration anatomically inappropriate and ineffective.
Anatomical Rationale
In patients with a colostomy, the fecal stream is diverted to exit through an abdominal stoma, completely bypassing the distal colon and rectum. The bisacodyl suppository is designed for rectal administration 1, where it works by direct contact with colonic mucosa to stimulate peristalsis and secretion 2. When the rectum is excluded from the fecal pathway, placing a suppository there serves no therapeutic purpose.
Mechanism of Action Considerations
Bisacodyl requires conversion to its active metabolite (BHPM) by small bowel and colonic mucosal deacetylase enzymes 2. The active metabolite acts directly on colonic mucosa to stimulate peristalsis and secretion. In a colostomy patient:
- The suppository would be placed in the rectal stump (if present), which is disconnected from the functioning bowel
- No fecal material passes through the rectum to be affected
- The medication cannot reach the proximal colon where stool is actually being formed and expelled through the stoma
Alternative Approaches
If constipation management is needed in a colostomy patient, consider:
- Oral bisacodyl (5 mg initially, can increase to 10 mg) 2 - works systemically after absorption and conversion in the functioning bowel segments
- Colostomy irrigation - though research shows mixed results with bisacodyl added to irrigation 3
- Suppositories inserted directly into the stoma - one pilot study explored glycerin suppositories inserted into sigmoid colostomies 4, though results showed the suppository often failed to remain in place long enough to be effective
Important Caveat
The FDA labeling clearly states bisacodyl suppositories are "For rectal use only" 1, with standard directions to "insert suppository well into rectum" 1. This labeling assumes an intact, functioning rectum connected to the bowel - a condition absent in colostomy patients.
The appropriate route for bisacodyl in colostomy patients is oral administration, starting at 5 mg and titrating as needed, with onset of action in 6-12 hours 2.